These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25664420)

  • 1. Risk of perimetric blindness among juvenile glaucoma patients.
    Gupta V; Devi K S; Kumar S; Pandey RM; Sihota R; Sharma A; Gupta S
    Ophthalmic Physiol Opt; 2015 Mar; 35(2):206-11. PubMed ID: 25664420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior rates of visual field loss and lifetime risk of blindness in glaucomatous patients undergoing trabeculectomy.
    Foulsham WS; Fu L; Tatham AJ
    Eye (Lond); 2015 Oct; 29(10):1353-9. PubMed ID: 26315699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myopia and glaucoma progression among patients with juvenile onset open angle glaucoma: A retrospective follow up study.
    Gupta S; Singh A; Mahalingam K; Selvan H; Gupta P; Pandey S; Somarajan BI; Gupta V
    Ophthalmic Physiol Opt; 2021 May; 41(3):475-485. PubMed ID: 33826775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics of Juvenile-onset Open Angle Glaucoma.
    Kwun Y; Lee EJ; Han JC; Kee C
    Korean J Ophthalmol; 2016 Apr; 30(2):127-33. PubMed ID: 27051261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Threat to fixation at diagnosis and lifetime risk of visual impairment in open-angle glaucoma.
    Peters D; Bengtsson B; Heijl A
    Ophthalmology; 2015 May; 122(5):1034-9. PubMed ID: 25537196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term structural and functional outcomes of therapy in juvenile-onset primary open-angle glaucoma: a five-year follow-up.
    Gupta V; Ov M; Rao A; Sharma A; Sihota R
    Ophthalmologica; 2012; 228(1):19-25. PubMed ID: 22156727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cataract extraction on the visual field decay rate in patients with glaucoma.
    Lee JW; Morales E; Yu F; Afifi AA; Kim EA; Abdollahi N; Nouri-Mahdavi K; Caprioli J
    JAMA Ophthalmol; 2014 Nov; 132(11):1296-302. PubMed ID: 25078978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blindness in patients with treated open-angle glaucoma.
    Chen PP
    Ophthalmology; 2003 Apr; 110(4):726-33. PubMed ID: 12689894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fellow eye prognosis in patients with severe visual field loss in 1 eye from chronic open-angle glaucoma.
    Chen PP; Bhandari A
    Arch Ophthalmol; 2000 Apr; 118(4):473-8. PubMed ID: 10766132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma.
    Kwon YH; Kim CS; Zimmerman MB; Alward WL; Hayreh SS
    Am J Ophthalmol; 2001 Jul; 132(1):47-56. PubMed ID: 11438053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHORT TERM EVALUATION OF PERIMETRIC PROGRESSION IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND DIABETES.
    Pantalon A; Feraru C; Chiseliţa D
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):83-9. PubMed ID: 27125077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline prognostic factors predict rapid visual field deterioration in glaucoma.
    Lee JM; Caprioli J; Nouri-Mahdavi K; Afifi AA; Morales E; Ramanathan M; Yu F; Coleman AL
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2228-36. PubMed ID: 24458154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime.
    Saunders LJ; Russell RA; Kirwan JF; McNaught AI; Crabb DP
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):102-9. PubMed ID: 24282228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change.
    Chauhan BC; Mikelberg FS; Artes PH; Balazsi AG; LeBlanc RP; Lesk MR; Nicolela MT; Trope GE;
    Arch Ophthalmol; 2010 Oct; 128(10):1249-55. PubMed ID: 20696979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of CYP1B1 Mutations in Juvenile Open-Angle Glaucoma With Advanced Visual Field Loss.
    Souzeau E; Hayes M; Zhou T; Siggs OM; Ridge B; Awadalla MS; Smith JE; Ruddle JB; Elder JE; Mackey DA; Hewitt AW; Healey PR; Goldberg I; Morgan WH; Landers J; Dubowsky A; Burdon KP; Craig JE
    JAMA Ophthalmol; 2015 Jul; 133(7):826-33. PubMed ID: 25950505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifetime risk of blindness in open-angle glaucoma.
    Peters D; Bengtsson B; Heijl A
    Am J Ophthalmol; 2013 Oct; 156(4):724-30. PubMed ID: 23932216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.